5DF血球分析仪检测白细胞分类计数与瑞氏染色镜检结果对比研究

目的　探讨5DF血球分析仪白细胞分类计数与传统的瑞氏染色镜检计数结果之间的差异。方法　用5分类血球分析仪和瑞氏染色法同时对10 0份血样进行分类计数,并用统计学分析研究。结果　中性粒细胞、嗜酸、嗜碱性细胞和淋巴细胞分类计数两法无明显差异(P均>0 .0 5 ) ,但单核细胞分类计数仪器法比镜检法结果偏高(P <0 .0 0 1)。结论　对于一般血液常规检查可选用仪器法筛查,而血液系统疾病或某种原因引起的细胞结构改变应选用镜检法。     

登革热监测系统概念数据模型构建

介绍概念数据模型的内涵以及应用概念数据模型的优势,应用场景分析方法对我国登革热监测各项活动进行梳理,构建由实体类以及实体类关联关系组成的登革热监测概念数据模型,为疾病监测相关信息系统建立统一的业务概念。     

可博利-2号在中老年男性雄激素部分缺乏症中的应用

【目的】探讨可博利-2号在中老年男性雄激素部分缺乏症中的疗效。【方法】中老年男性雄激素部分缺乏症60例（观察组）,中青年男性健康者60例（对照组）,两组均用可博利-2号口服液,每次10 ml,每日3次,疗程2~3个月,观察症状改善情况,检测血睾酮、一氧化氮、雌二醇和经腹B超测前列腺大小综合分析。【结果】观察组49例患者症状明显改善,血睾酮、一氧化氮均上升,雌二醇无明显变化,前列腺体积增大;对照组血睾酮、一氧化氮、雌二醇和前列腺大小均无变化。【结论】可博利-2号治疗中老年男性雄激素部分缺乏症效果良好、使用安全,值得更进一步研究和开发应用。     

Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation

Background

The underlying mechanisms sustaining human persistent atrial fibrillation (PsAF) is poorly understood.

Is asthma a protective factor for dengue fever? In vitro experiment and nationwide population-based cohort analysis

BackgroundDengue fever (DF) is the most rapidly spreading mosquito-borne viral disease. Practical vaccines or specific therapeutics are still expected. Environmental factors and genetic factors affect the susceptibility of Dengue virus (DV) infection. Asthma is a common allergic disease, with house dust mites (HDMs) being the most important allergens. Asthmatic patients are susceptible to several microorganism infections.MethodsA nationwide population-based cohort analysis was designed to assess whether to determine whether asthma can be a risk factor for DF.ResultsUnexpectedly, our data from a nationwide population-based cohort revealed asthmatic patients are at a decreased risk of DF. Compared to patients without asthma, the hazard ratio (HR) for DF in patients with asthma was 0.166 (95% CI: 0.118–0.233) after adjustment for possible confounding factors. In the age stratification, the adjusted HR for DF in young adult patients with asthma was 0.063. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) of dendritic cells (DCs) is an important entry for DV. Through another in vitro experiment, we found that HDM can diminish surface expression of DC-SIGN in monocyte-derived DCs and further decrease the cellular entry of DV.ConclusionsDecreased DC-SIGN expression in DCs of allergic asthmatic patient may be one of many factors for them to be protected against DF. This could implicate the potential for DC-SIGN modulation as a candidate target for designing therapeutic strategies for DF.     

糖尿病足中医证型与下肢动脉彩超相关性研究

目的 初步探讨糖尿病足中医不同证型与下肢动脉彩超的关系.方法 收集糖尿病足病例60例,非糖尿病住院病人45例作为对照组,记录相应下肢动脉彩超结果,并进行初步相关性分析.结果 与非糖尿病组比较,糖尿病足组双下肢动脉内径均较窄,其中股总动脉、腘动脉、胫前动脉、胫后动脉内径差异有统计学意义(P＜0.01);分型研究中,气阴两虚瘀阻组各下肢动脉内径最窄,与其他证型组比较差异有统计学意义(P＜0.01或P＜0.05).结论 糖尿病足中医不同征型与下肢动脉彩超有一定的相关性,糖尿病足表现为各下肢动脉内径变窄,以气阴两虚瘀阻型明显.     

Low-density lipoprotein apheresis in the treatment of peripheral arterial disease

Low-density lipoprotein (LDL) apheresis is performed in patients with homozygous familial hyper-cholesterolemia who lack LDL receptors and with heterozygous familial hypercholesterolemia who are LDL receptor deficient with documented, symptomatic coronary artery disease who are resistant to diet changes and maximum drug therapy. LDL apheresis can reduce or abolish anginal symptoms and improve coronary lesions. Several reports reveal the improvement of insufficient peripheral blood flow. By extensively removing blood LDL and changing coagulation factors and various vasoactive substances, LDL apheresis improves blood rheology and thereby peripheral circulation. It seems worth trying on all patients with arteriosclerotic lesions, even if they are normocholesterolemic.     

后程加速超分割放疗合并DF方案化疗治疗中晚期食管癌临床研究

目的探讨DF方案化疗合并后程加速超分割放疗治疗中、晚期食管癌的临床应用价值。方法经病理确诊的中、晚期食管癌90例随机分为两组(单放组和化放组),每组45例;放疗均采用6MVX线外照射,单放组常规分割治疗2Gy/次,5次/周,全疗程总剂量70Gy;化放组放疗前2/3疗程常规放疗2Gy/次,5次/周,共40Gy,后1/3疗程改用加速超分割治疗,1.5Gy/次,2次/天,间隔6h以上,全疗程总剂量70Gy,前程配合DF方案化疗,治疗结束后,按照食管癌诊治规范标准,比较两组疗效及1、3年生存率。结果单放组CR44%,PR51%,1、3年生存率分别为42%、28%;化放组CR51%,PR57%,1、3年生存率分别为74%、53%,经统计学处理两者生存率比较差异有统计学意义(P<0.05),毒副作用两组比较差异无统计学意义(P>0.05)。结论后程加速超分割放疗加DF增敏化疗能明显提高中、晚期食管癌的近期疗效及1、3年生存率,且不增加毒副反应,值得推广应用。